Kucinski Keith A 4
4 · Matinas BioPharma Holdings, Inc. · Filed Nov 26, 2019
Insider Transaction Report
Form 4
Kucinski Keith A
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2019-11-25$1.23/sh+58,000$71,160→ 94,500 total - Purchase
Common Stock, par value $0.0001 per share
2019-11-22$1.20/sh+36,500$43,807→ 36,500 total
Footnotes (1)
- [F1]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.17 to $1.23, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.